All lobbying filings
Novavax, Inc.
Novavax, Inc. filed a Q3 report for Novavax, Inc. on October 14, 2026.
Lobbying for Novavax, Inc.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 14, 2026
Expenses
$120,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Maryland
Government bodies contacted
2
Lobbying activity
1
Issues related to federal vaccine programs and vaccine regulatory frameworks